Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes.

These results could reflect ongoing β cell death in individuals with longstanding T1D, even in the absence of detectable C-peptide production, suggesting that therapies targeting β cell survival could be beneficial among individuals with longstanding T1D.